Highly efficient CRISPR/ Cas9-mediated cloning and functional characterization of gastric cancer-derived Epstein-Barr virus strains

Journal of Virology

Volumn 90, Issue 9, 2016, Pages 4383-4393

  Kanda, Teru ^a,d   Furuse, Yuki ^b   Oshitani, Hitoshi ^b   Kiyono, Tohru ^c  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^d TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 9; ONCOPROTEIN; RAS PROTEIN; VIRUS DNA; VIRAL PROTEIN;

ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CELL DEATH; CELL DEGENERATION; CELL SURVIVAL; CELL VACUOLE; CONTROLLED STUDY; CRISPR CAS SYSTEM; DNA CLEAVAGE; DNA REPAIR; DNA SEQUENCE; DNA STRAND BREAKAGE; EPISOME; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GASTRIC CANCER CELL LINE; GENETIC VARIATION; HUMAN; HUMAN CELL; IMMORTALIZED CELL LINE; KERATINOCYTE; LATENT VIRUS INFECTION; MALIGNANT TRANSFORMATION; MOLECULAR CLONING; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; SNU719 CELL LINE; STOMACH CANCER; VIRUS CARCINOGENESIS; VIRUS CHARACTERIZATION; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS STRAIN; YCCEL1 CELL LINE; BIOLOGY; CHEMISTRY; COMPLICATION; CYTOPATHOGENIC EFFECT; GENE TARGETING; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYLOGENY; PLASMID; PROCEDURES; SEQUENCE ALIGNMENT; STOMACH NEOPLASMS; TUMOR CELL LINE; VIROLOGY; VIRUS REPLICATION;

BASE SEQUENCE; CELL LINE, TUMOR; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CLONING, MOLECULAR; COMPUTATIONAL BIOLOGY; CRISPR-CAS SYSTEMS; CYTOPATHOGENIC EFFECT, VIRAL; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; GENE TARGETING; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; MOLECULAR SEQUENCE ANNOTATION; MOLECULAR SEQUENCE DATA; PHYLOGENY; PLASMIDS; RAS PROTEINS; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; STOMACH NEOPLASMS; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84964931498     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00060-16     Document Type: Article

References (38)

1. Rickinson AB, Kieff E. 2007. Epstein-Barr virus, p 2603-2654. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Cancer Genome Atlas Research Network. 2014. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513:202-209. http://dx.doi.org/10.1038/nature13480.
3. Tsao SW, Tsang CM, Pang PS, Zhang G, Chen H, Lo KW. 2012. The biology of EBV infection in human epithelial cells. Semin Cancer Biol 22:137-143. http://dx.doi.org/10.1016/j.semcancer.2012.02.004.
4. Lin Z, Wang X, Strong MJ, Concha M, Baddoo M, Xu G, Baribault C, Fewell C, Hulme W, Hedges D, Taylor CM, Flemington EK. 2013. Whole-genome sequencing of the Akata and Mutu Epstein-Barr virus strains. J Virol 87:1172-1182. http://dx.doi.org/10.1128/JVI.02517-12.
5. Palser AL, Grayson NE, White RE, Corton C, Correia S, Ba Abdullah MM, Watson SJ, Cotten M, Arrand JR, Murray PG, Allday MJ, Rickinson AB, Young LS, Farrell PJ, Kellam P. 2015. Genome diversity of Epstein-Barr virus from multiple tumor types and normal infection. J Virol 89:5222-5237. http://dx.doi.org/10.1128/JVI.03614-14.
6. Kwok H, Wu CW, Palser AL, Kellam P, Sham PC, Kwong DL, Chiang AK. 2014. Genomic diversity of Epstein-Barr virus genomes isolated from primary nasopharyngeal carcinoma biopsy samples. J Virol 88:10662-10672 http://dx.doi.org/10.1128/JVI.01665-14.
7. Tsai MH, Raykova A, Klinke O, Bernhardt K, Gartner K, Leung CS, Geletneky K, Sertel S, Munz C, Feederle R, Delecluse HJ. 2013. Spontaneous lytic replication and epitheliotropism define an Epstein-Barr virus strain found in carcinomas. Cell Rep 5:458-470. http://dx.doi.org/10.1016/j.celrep.2013.09.012.
8. Wang J, Quake SR. 2014. RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection. Proc Natl Acad Sci U S A 111:13157-13162. http://dx.doi.org/10.1073/pnas.1410785111.
9. Yuen KS, Chan CP, Wong NH, Ho CH, Ho TH, Lei T, Deng W, Tsao SW, Chen H, Kok KH, Jin DY. 2015. CRISPR/Cas9-mediated genome editing of Epstein-Barr virus in human cells. J Gen Virol 96:626-636. http://dx.doi.org/10.1099/jgv.0.000012.
10. Bi Y, Sun L, Gao D, Ding C, Li Z, Li Y, Cun W, Li Q. 2014. Highefficiency targeted editing of large viral genomes by RNA-guided nucleases. PLoS Pathog 10:e1004090. http://dx.doi.org/10.1371/journal.ppat.1004090.
11. Suenaga T, Kohyama M, Hirayasu K, Arase H. 2014. Engineering large viral DNA genomes using the CRISPR-Cas9 system. Microbiol Immunol 58:513-522. http://dx.doi.org/10.1111/1348-0421.12180.
12. Oh ST, Seo JS, Moon UY, Kang KH, Shin DJ, Yoon SK, Kim WH, Park JG, Lee SK. 2004. A naturally derived gastric cancer cell line shows latency I Epstein-Barr virus infection closely resembling EBV-associated gastric cancer. Virology 320:330-336. http://dx.doi.org/10.1016/j.virol.2003.12.005.
13. Kim DN, Seo MK, Choi H, Kim SY, Shin HJ, Yoon AR, Tao Q, Rha SY, Lee SK. 2013. Characterization of naturally Epstein-Barr virus-infected gastric carcinoma cell line YCCEL1. J Gen Virol 94:497-506. http://dx.doi.org/10.1099/vir.0.045237-0.
14. Kanda T, Miyata M, Kano M, Kondo S, Yoshizaki T, Iizasa H. 2015. Clustered microRNAs of the Epstein-Barr virus cooperatively downregulate an epithelial cell-specific metastasis suppressor. J Virol 89:2684-2697. http://dx.doi.org/10.1128/JVI.03189-14.
15. Egawa N, Nakahara T, Ohno S, Narisawa-Saito M, Yugawa T, Fujita M, Yamato K, Natori Y, Kiyono T. 2012. The E1 protein of human papillomavirus type 16 is dispensable for maintenance replication of the viral genome. J Virol 86:3276-3283. http://dx.doi.org/10.1128/JVI.06450-11.
16. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, Zhang F. 2013. Multiplex genome engineering using CRISPR/Cas systems. Science 339:819-823. http://dx.doi.org/10.1126/science.1231143.
17. Shimada A, Dohke K, Sadaie M, Shinmyozu K, Nakayama J, Urano T, Murakami Y. 2009. Phosphorylation of Swi6/HP1 regulates transcriptional gene silencing at heterochromatin. Genes Dev 23:18-23. http://dx.doi.org/10.1101/gad.1708009.
18. Kanda T, Yajima M, Ahsan N, Tanaka M, Takada K. 2004. Production of high-titer Epstein-Barr virus recombinants derived from Akata cells by using a bacterial artificial chromosome system. J Virol 78:7004-7015. http://dx.doi.org/10.1128/JVI.78.13.7004-7015.2004.
19. Kanda T, Shibata S, Saito S, Murata T, Isomura H, Yoshiyama H, Takada K, Tsurumi T. 2011. Unexpected instability of Family of Repeats (FR), the critical cis-acting sequence required for EBV latent infection, in EBV-BAC Systems. PLoS One 6:e27758. http://dx.doi.org/10.1371/journal.pone.0027758.
20. Eid J, Fehr A, Gray J, Luong K, Lyle J, Otto G, Peluso P, Rank D, Baybayan P, Bettman B, Bibillo A, Bjornson K, Chaudhuri B, Christians F, Cicero R, Clark S, Dalal R, Dewinter A, Dixon J, Foquet M, Gaertner A, Hardenbol P, Heiner C, Hester K, Holden D, Kearns G, Kong X, Kuse R, Lacroix Y, Lin S, Lundquist P, Ma C, Marks P, Maxham M, Murphy D, Park I, Pham T, Phillips M, Roy J, Sebra R, Shen G, Sorenson J, Tomaney A, Travers K, Trulson M, Vieceli J, Wegener J, Wu D, Yang A, Zaccarin D, Zhao P, Zhong F, Korlach J, Turner S. 2009. Real-time DNA sequencing from single polymerase molecules. Science 323:133-138. http://dx.doi.org/10.1126/science.1162986.
21. Chin CS, Alexander DH, Marks P, Klammer AA, Drake J, Heiner C, Clum A, Copeland A, Huddleston J, Eichler EE, Turner SW, Korlach J. 2013. Nonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data. Nat Methods 10:563-569. http://dx.doi.org/10.1038/nmeth.2474.
22. de Jesus O, Smith PR, Spender LC, Elgueta Karstegl C, Niller HH, Huang D, Farrell PJ. 2003. Updated Epstein-Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAs of EBV. J Gen Virol 84:1443-1450. http://dx.doi.org/10.1099/vir.0.19054-0.
23. Tcherepanov V, Ehlers A, Upton C. 2006. Genome Annotation Transfer Utility (GATU): rapid annotation of viral genomes using a closely related reference genome. BMC Genomics 7:150. http://dx.doi.org/10.1186/1471-2164-7-150.
24. Tamura K, Nei M. 1993. Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol Biol Evol 10:512-526.
25. Dajee M, Tarutani M, Deng H, Cai T, Khavari PA. 2002. Epidermal Ras blockade demonstrates spatially localized Ras promotion of proliferation and inhibition of differentiation. Oncogene 21:1527-1538. http://dx.doi.org/10.1038/sj.onc.1205287.
26. Mashiko D, Fujihara Y, Satouh Y, Miyata H, Isotani A, Ikawa M. 2013. Generation of mutant mice by pronuclear injection of circular plasmid expressing Cas9 and single guided RNA. Sci Rep 3:3355. http://dx.doi.org/10.1038/srep03355.
27. Zeng MS, Li DJ, Liu QL, Song LB, Li MZ, Zhang RH, Yu XJ, Wang HM, Ernberg I, Zeng YX. 2005. Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient. J Virol 79: 15323-15330. http://dx.doi.org/10.1128/JVI.79.24.15323-15330.2005.
28. Feederle R, Klinke O, Kutikhin A, Poirey R, Tsai MH, Delecluse HJ. 2015. Epstein-Barr virus: from the detection of sequence polymorphisms to the recognition of viral types. Curr Top Microbiol Immunol 390:119-148. http://dx.doi.org/10.1007/978-3-319-22822-8_7.
29. Song KA, Yang SD, Hwang J, Kim JI, Kang MS. 2015. The full-length DNA sequence of Epstein Barr virus from a human gastric carcinoma cell line, SNU-719. Virus Genes 51:329-337. http://dx.doi.org/10.1007/s11262-015-1248-z.
30. Birdwell CE, Queen KJ, Kilgore PC, Rollyson P, Trutschl M, Cvek U, Scott RS. 2014. Genome-wide DNA methylation as an epigenetic consequence of Epstein-Barr virus infection of immortalized keratinocytes. J Virol 88:11442-11458. http://dx.doi.org/10.1128/JVI.00972-14.
31. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. 1997. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593-602. http://dx.doi.org/10.1016/S0092-8674(00)81902-9.
32. Chi S, Kitanaka C, Noguchi K, Mochizuki T, Nagashima Y, Shirouzu M, Fujita H, Yoshida M, Chen W, Asai A, Himeno M, Yokoyama S, Kuchino Y. 1999. Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells. Oncogene 18:2281-2290. http://dx.doi.org/10.1038/sj.onc.1202538.
33. Farrell PJ. 2015. Epstein-Barr virus strain variation. Curr Top Microbiol Immunol 390:45-69. http://dx.doi.org/10.1007/978-3-319-22822-8_4.
34. Tombácz D, Sharon D, Olah P, Csabai Z, Snyder M, Boldogkoi Z. 2014. Strain Kaplan of pseudorabies virus genome sequenced by PacBio singlemolecule real-time sequencing technology. Genome Announc 2:e00628-14. http://dx.doi.org/10.1128/genomeA.00628-14.
35. Tsang CM, Yip YL, Lo KW, Deng W, To KF, Hau PM, Lau VM, Takada K, Lui VW, Lung ML, Chen H, Zeng M, Middeldorp JM, Cheung AL, Tsao SW. 2012. Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells. Proc Natl Acad Sci U S A 109:E3473-E3482. http://dx.doi.org/10.1073/pnas.1202637109.
36. Liang Q, Yao X, Tang S, Zhang J, Yau TO, Li X, Tang CM, Kang W, Lung RW, Li JW, Chan TF, Xing R, Lu Y, Lo KW, Wong N, To KF, Yu C, Chan FK, Sung JJ, Yu J. 2014. Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer. Gastroenterology 147:1350-1362.e4. http://dx.doi.org/10.1053/j.gastro.2014.08.036.
37. Kimura H, Ito Y, Kawabe S, Gotoh K, Takahashi Y, Kojima S, Naoe T, Esaki S, Kikuta A, Sawada A, Kawa K, Ohshima K, Nakamura S. 2012. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood 119:673-686. http://dx.doi.org/10.1182/blood-2011-10-381921.
38. Kanda T, Kamiya M, Maruo S, Iwakiri D, Takada K. 2007. Symmetrical localization of extrachromosomally replicating viral genomes on sister chromatids. J Cell Sci 120:1529-1539. http://dx.doi.org/10.1242/jcs.03434.